.png)
Epilepsy Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 159 Category: Pharma & Healthcare Report Code : HC0114743
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Epilepsy Market By Product Type (Partial/focal Seizure, Generalized Seizure, Myoclonus Misses) and Application (Hospitals, Neurology Centers, Home Care Settings, Ambulatory Surgical Centers, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Epilepsy Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Epilepsy may occur as a result of a genetic disorder or an acquired brain injury, such as a trauma or stroke. During a seizure, a person experiences abnormal behavior, symptoms and sensations, sometimes including loss of consciousness.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Epilepsy Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- LivaNova
- Johnson & Johnson Services
- Eisai
- GlaxoSmithKline PLC
- Pfizer
- UCB SA
- Medtronic PLC (Ireland)
- NeuroPace
- Novartis AG
- GW Pharmaceuticals
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Epilepsy Market, ByProduct Type, Estimates and Forecast, 2017-2027 ($Million)
o Partial/focal Seizure
o Generalized Seizure
o Myoclonus Misses
· Epilepsy Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Neurology Centers
o Home Care Settings
o Ambulatory Surgical Centers
o Others
· Epilepsy Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o LivaNova
o Johnson & Johnson Services
o Eisai
o GlaxoSmithKline PLC
o Pfizer
o UCB SA
o Medtronic PLC (Ireland)
o NeuroPace
o Novartis AG
· Epilepsy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Epilepsy Market, By Country
o U.S. Epilepsy Market
o Canada Epilepsy Market
o Mexico Epilepsy Market
o Europe
§ Europe Epilepsy Market, By Country
· Germany Epilepsy Market
o UK Epilepsy Market
o France Epilepsy Market
o RussiaEpilepsy Market
o Italy Epilepsy Market
o Rest of Europe Epilepsy Market
o Asia-Pacific
§ Asia-Pacific Epilepsy Market, By Country
o ChinaEpilepsy Market
o Japan Epilepsy Market
o South KoreaEpilepsy Market
o India Epilepsy Market
o Southeast AsiaEpilepsy Market
o Rest of Asia-Pacific Epilepsy Market
o South America
§ South AmericaEpilepsy Market
o Brazil Epilepsy Market
o ArgentinaEpilepsy Market
o ColumbiaEpilepsy Market
o Rest of South America Epilepsy Market
o Middle East and Africa
§ Middle East and AfricaEpilepsy Market
o Saudi ArabiaEpilepsy Market
o UAEEpilepsy Market
o EgyptEpilepsy Market
o NigeriaEpilepsy Market
o South Africa Epilepsy Market
o Rest of MEA Epilepsy Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Epilepsy Market, By Product Type
5.1. Introduction
5.2. Global Epilepsy Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Epilepsy Revenue and Revenue Share by Product Type (2017-2021)
5.3. Partial/focal Seizure
5.3.1. Global Partial/focal Seizure Revenue and Growth Rate (2017-2021)
5.4. Generalized Seizure
5.4.1. Global Generalized Seizure Revenue and Growth Rate (2017-2021)
5.5. Myoclonus Missesre
5.5.1. Global Myoclonus Missesre Revenue and Growth Rate (2017-2021)
5.6. Generalized Seizure
5.6.1. Global Generalized Seizure Revenue and Growth Rate (2017-2021)
5.7. Myoclonus Misses
5.7.1. Global Myoclonus Misses Revenue and Growth Rate (2017-2021)
6. Epilepsy Market, By Application
6.1. Introduction
6.2. Global Epilepsy Revenue and Market Share by Application (2017-2021)
6.2.1. Global Epilepsy Revenue and Revenue Share by Application (2017-2021)
6.3. Hospitals
6.3.1. Global Hospitals Revenue and Growth Rate (2017-2021)
6.4. Neurology Centers
6.4.1. Global Neurology Centers Revenue and Growth Rate (2017-2021)
6.5. Home Care Settings
6.5.1. Global Home Care Settings Revenue and Growth Rate (2017-2021)
6.6. Ambulatory Surgical Centers
6.6.1. Global Ambulatory Surgical Centers Revenue and Growth Rate (2017-2021)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2021)
7. Epilepsy Market, By Region
7.1. Introduction
7.2. Global Epilepsy Revenue and Market Share by Regions
7.2.1. Global Epilepsy Revenue by Regions (2017-2021)
7.3. North America Epilepsy by Countries
7.3.1. North America Epilepsy Revenue and Growth Rate (2017-2021)
7.3.2. North America Epilepsy Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Epilepsy by Countries
7.4.1. Europe Epilepsy Revenue and Growth Rate (2017-2021)
7.4.2. Europe Epilepsy Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Epilepsy by Countries
7.5.1. Asia-Pacific Epilepsy Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Epilepsy Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Epilepsy by Countries
7.6.1. South America Epilepsy Revenue and Growth Rate (2017-2021)
7.6.2. South America Epilepsy Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Epilepsy by Countries
7.7.1. Middle East and Africa Epilepsy Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Epilepsy Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Epilepsy Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. LivaNova
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Johnson & Johnson Services
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Eisai
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. GlaxoSmithKline PLC
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Pfizer
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. UCB SA
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Medtronic PLC (Ireland)
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. NeuroPace
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Novartis AG
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. GW Pharmaceuticals
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Epilepsy Market Forecast (2022-2027)
9.1. Global Epilepsy Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Epilepsy Market Forecast by Regions (2022-2027)
9.2.1. North America Epilepsy Market Forecast (2022-2027)
9.2.1.1. United States Epilepsy Market Forecast (2022-2027)
9.2.1.2. Canada Epilepsy Market Forecast (2022-2027)
9.2.1.3. Mexico Epilepsy Market Forecast (2022-2027)
9.2.2. Europe Epilepsy Market Forecast (2022-2027)
9.2.2.1. Germany Epilepsy Market Forecast (2022-2027)
9.2.2.2. France Epilepsy Market Forecast (2022-2027)
9.2.2.3. UK Epilepsy Market Forecast (2022-2027)
9.2.2.4. Russia Epilepsy Market Forecast (2022-2027)
9.2.2.5. Italy Epilepsy Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Epilepsy Market Forecast (2022-2027)
9.2.3. Asia-Pacific Epilepsy Market Forecast (2022-2027)
9.2.3.1. China Epilepsy Market Forecast (2022-2027)
9.2.3.2. Japan Epilepsy Market Forecast (2022-2027)
9.2.3.3. Korea Epilepsy Market Forecast (2022-2027)
9.2.3.4. India Epilepsy Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Epilepsy Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Epilepsy Market Forecast (2022-2027)
9.2.4. South America Epilepsy Market Forecast (2022-2027)
9.2.4.1. Brazil Epilepsy Market Forecast (2022-2027)
9.2.4.2. Argentina Epilepsy Market Forecast (2022-2027)
9.2.4.3. Columbia Epilepsy Market Forecast (2022-2027)
9.2.4.4. Rest of South America Epilepsy Market Forecast (2022-2027)
9.2.5. Middle East and Africa Epilepsy Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Epilepsy Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Epilepsy Market Forecast (2022-2027)
9.2.5.3. Egypt Epilepsy Market Forecast (2022-2027)
9.2.5.4. Nigeria Epilepsy Market Forecast (2022-2027)
9.2.5.5. South Africa Epilepsy Market Forecast (2022-2027)
9.2.5.6. Turkey Epilepsy Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Epilepsy Market Forecast (2022-2027)
9.3. Epilepsy Market Forecast by Product Type (2022-2027)
9.3.1. Epilepsy Forecast by Product Type (2022-2027)
9.3.2. Epilepsy Market Share Forecast by Product Type (2022-2027)
9.4. Epilepsy Market Forecast by Application (2022-2027)
9.4.1. Epilepsy Forecast by Application (2022-2027)
9.4.2. Epilepsy Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Epilepsy Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Epilepsy Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Partial/focal Seizure Revenue and Growth Rate (2017-2019)
Figure Global Generalized Seizure Revenue and Growth Rate (2017-2019)
Figure Global Myoclonus Missesre Revenue and Growth Rate (2017-2019)
Figure Global Generalized Seizure Revenue and Growth Rate (2017-2019)
Figure Global Myoclonus Misses Revenue and Growth Rate (2017-2019)
Table Global Epilepsy Revenue and Revenue Share by Application (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Neurology Centers Revenue and Growth Rate (2017-2019)
Figure Global Home Care Settings Revenue and Growth Rate (2017-2019)
Figure Global Ambulatory Surgical Centers Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Epilepsy Revenue by Regions (2017-2019)
Figure North America Epilepsy Growth Rate (2017-2019)
Figure North America Epilepsy Revenue and Growth Rate (2017-2019)
Figure North America Epilepsy by Countries (2017-2019)
Figure North America Epilepsy Revenue (Million USD) by Countries (2017-2019)
Figure United States Epilepsy Growth Rate (2017-2019)
Figure United States Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Epilepsy Growth Rate (2017-2019)
Figure Canada Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Epilepsy Growth Rate (2017-2019)
Figure Mexico Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Epilepsy Growth Rate (2017-2019)
Figure Europe Epilepsy Revenue and Growth Rate (2017-2019)
Figure Europe Epilepsy by Countries (2017-2019)
Figure Europe Epilepsy Revenue (Million USD) by Countries (2017-2019)
Figure Germany Epilepsy Growth Rate (2017-2019)
Figure Germany Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Epilepsy Growth Rate (2017-2019)
Figure France Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Epilepsy Growth Rate (2017-2019)
Figure UK Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Epilepsy Growth Rate (2017-2019)
Figure Russia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Epilepsy Growth Rate (2017-2019)
Figure Italy Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Epilepsy Growth Rate (2017-2019)
Figure Rest of Europe Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Epilepsy Growth Rate (2017-2019)
Figure Asia-Pacific Epilepsy Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Epilepsy by Countries (2017-2019)
Figure Asia-Pacific Epilepsy Revenue (Million USD) by Countries (2017-2019)
Figure China Epilepsy Growth Rate (2017-2019)
Figure China Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Epilepsy Growth Rate (2017-2019)
Figure Japan Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Epilepsy Growth Rate (2017-2019)
Figure Korea Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Epilepsy Growth Rate (2017-2019)
Figure India Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Epilepsy Growth Rate (2017-2019)
Figure Southeast Asia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Epilepsy Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Epilepsy Growth Rate (2017-2019)
Figure South America Epilepsy Revenue and Growth Rate (2017-2019)
Figure South America Epilepsy by Countries (2017-2019)
Figure South America Epilepsy Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Epilepsy Growth Rate (2017-2019)
Figure Brazil Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Epilepsy Growth Rate (2017-2019)
Figure Argentina Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Epilepsy Growth Rate (2017-2019)
Figure Columbia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Epilepsy Growth Rate (2017-2019)
Figure Rest of South America Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Epilepsy Growth Rate (2017-2019)
Figure Middle East and Africa Epilepsy Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Epilepsy by Countries (2017-2019)
Figure Middle East and Africa Epilepsy Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Epilepsy Growth Rate (2017-2019)
Figure Saudi Arabia Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Epilepsy Growth Rate (2017-2019)
Figure United Arab Emirates Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Epilepsy Growth Rate (2017-2019)
Figure Egypt Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Epilepsy Growth Rate (2017-2019)
Figure Nigeria Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Epilepsy Growth Rate (2017-2019)
Figure South Africa Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Epilepsy Growth Rate (2017-2019)
Figure Turkey Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Epilepsy Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Epilepsy Revenue (Millions USD) and Growth Rate (2017-2019)
Table LivaNova Epilepsy Financial Overview
Table Johnson & Johnson Services Epilepsy Financial Overview
Table Eisai Epilepsy Financial Overview
Table GlaxoSmithKline PLC Epilepsy Financial Overview
Table Pfizer Epilepsy Financial Overview
Table UCB SA Epilepsy Financial Overview
Table Medtronic PLC (Ireland) Epilepsy Financial Overview
Table NeuroPace Epilepsy Financial Overview
Table Novartis AG Epilepsy Financial Overview
Table GW Pharmaceuticals Epilepsy Financial Overview
Figure Global Epilepsy Revenue (Millions USD) and Growth Rate (2019-2027)
Table Epilepsy Market Forecast by Regions (2019-2027)
Figure North America Epilepsy Market Forecast (2019-2027)
Figure United States Epilepsy Market Forecast (2019-2027)
Figure Canada Epilepsy Market Forecast (2019-2027)
Figure Mexico Epilepsy Market Forecast (2019-2027)
Figure Europe Epilepsy Market Forecast (2019-2027)
Figure Germany Epilepsy Market Forecast (2019-2027)
Figure France Epilepsy Market Forecast (2019-2027)
Figure UK Epilepsy Market Forecast (2019-2027)
Figure Russia Epilepsy Market Forecast (2019-2027)
Figure Italy Epilepsy Market Forecast (2019-2027)
Figure Rest of Europe Epilepsy Market Forecast (2019-2027)
Figure Asia-Pacific Epilepsy Market Forecast (2019-2027)
Figure China Epilepsy Market Forecast (2019-2027)
Figure Japan Epilepsy Market Forecast (2019-2027)
Figure Korea Epilepsy Market Forecast (2019-2027)
Figure India Epilepsy Market Forecast (2019-2027)
Figure Southeast Asia Epilepsy Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Epilepsy Market Forecast (2019-2027)
Figure South America Epilepsy Market Forecast (2019-2027)
Figure Brazil Epilepsy Market Forecast (2019-2027)
Figure Argentina Epilepsy Market Forecast (2019-2027)
Figure Columbia Epilepsy Market Forecast (2019-2027)
Figure Rest of South America Epilepsy Market Forecast (2019-2027)
Figure Middle East and Africa Epilepsy Market Forecast (2019-2027)
Figure Saudi Arabia Epilepsy Market Forecast (2019-2027)
Figure United Arab Emirates Epilepsy Market Forecast (2019-2027)
Figure Egypt Epilepsy Market Forecast (2019-2027)
Figure Nigeria Epilepsy Market Forecast (2019-2027)
Figure South Africa Epilepsy Market Forecast (2019-2027)
Figure Turkey Epilepsy Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Epilepsy Market Forecast (2019-2027)
Figure Global Epilepsy Forecast by Product Type (2019-2027)
Figure Global Epilepsy Market Share Forecast by Product Type (2019-2027)
Figure Global Epilepsy Forecast by Product Type (2019-2027)
Figure Global Epilepsy Forecast by Application (2019-2027)
Figure Global Epilepsy Market Share Forecast by Application (2019-2027)
Figure Global Epilepsy Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|